These findings suggested that EGB761 may improve spatial cognitive dysfunction by ameliorating the synaptic plasticity impairment, synaptic degeneration, and axon demyelination by rectifying the inhibition of the mTOR signaling pathway occurring after CCH. Here, MTOR is linked to columnar cell hyperplasia of the breast.